#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Choroidal dystrophy Retinal dystrophy Progressive supranuclear palsy Subarachnoid haemorrhage Immunodeficiency Cardiomyopathy Squamous cell carcinoma of the oral cavity Biliary neoplasm Multiple system atrophy Hypocalcaemia Pustular psoriasis Cystic fibrosis respiratory infection suppression Head and neck cancer Acute promyelocytic leukaemia Acute graft versus host disease in intestine More trials…

    Learn about Rare Diseases

    Isodicentric chromosome 15 syndrome – Trials in Disease Netherton’s syndrome – Diagnostics Haemolytic uraemic syndrome – Trials in Disease Pemphigus – Trials in Disease Castleman’s disease – Diagnostics Lymphangioma – Trials in Disease Combined immunodeficiency – Trials in Disease Pleomorphic leiomyosarcoma – Diagnostics Synovial sarcoma recurrent – Treatment Crigler-Najjar syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lazertinib Nortriptyline Hydrochloride Cefiderocol Rhh646 Cd7-Cart01 Arbaclofen Cefuroxime Sodium Oxybutynin MB-HUCART19.1 COLESEVELAM HYDROCHLORIDE Rbl015.2 Human Albumin Solution APAZUNERSEN Erythromycin Lactobionate Alendronic Acid Cldn6 Car-T Lisinopril Dihydrate Crofelemer Pomalidomide Arsenic Trioxide More therapies…

    Learn about Your Condition

    Tuberculosis Procedural anxiety Osteogenesis imperfecta Postoperative delirium Iron overload Intestinal ischaemia Hyperphagia Diabetes mellitus Diabetic retinopathy Bile acid synthesis disorder Rubella Triple positive breast cancer Staphylococcal infection Varices oesophageal Peritoneal abscess More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Cisplatin
    France

  • Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Lomustine
    • Vincristine
    • Carboplatin
    Austria Belgium Czechia Finland France Germany +4

  • Study on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Colchicine
    France

  • Study on Ruxolitinib for Treating Inclusion Body Myositis in Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Inclusion body myositis
    Investigated Drugs:
    • Ruxolitinib
    France

  • Study Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mycobacterium avium complex infection
    Investigated Drugs:
    • Azithromycin
    • Clarithromycin
    • Ethambutol Hydrochloride
    France

  • Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Epirubicin Hydrochloride
    • Paclitaxel
    France

  • Study on Apixaban for Blood Clot Prevention in New Multiple Myeloma Patients and Those Having Knee Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Apixaban
    France

  • Comparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hydroxycarbamide
    • Peginterferon Alfa-2A
    • Ruxolitinib
    France

  • Study of Eculizumab in Adults with Hypertensive Emergency-Related Hemolytic Uremic Syndrome Requiring Dialysis or with Severe Kidney Problems

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atypical haemolytic uraemic syndrome
    Investigated Drugs:
    • Eculizumab
    France

  • Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ependymoma
    Investigated Drugs:
    • Sodium Valproate
    • Cisplatin
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland France +7
Previous Page
1 … 11 12 13 14 15 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!